Physician profile
James Brown
NPI 1134190077
$4,651.14
in general payments reported to CMS, 2019-2025
39 companies · $961 in 2025
The $961 reported for 2025 was more than what 84% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,064 · 2020: $505 · 2021: $582 · 2022: $512 · 2023: $494 · 2024: $533 · 2025: $961.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,988.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,987.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $695.89 | 2019-2025 | Evenity, Prolia, Otezla |
| Amarin Pharma, INC. | $544.85 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $400.26 | 2022-2025 | |
| Pfizer INC. | $379.52 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $332.87 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Abbvie INC. | $208.07 | 2021-2023 | Vraylar |
| Astellas Pharma US INC | $183.66 | 2022-2025 | Veozah |
| Novo Nordisk INC | $178.66 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $168.85 | 2019-2025 | Jardiance |
| Lilly USA, LLC | $156.30 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Sunovion Pharmaceuticals INC. | $122.83 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $112.96 | 2021-2022 | |
| Medtronic, INC. | $110.36 | 2024-2025 | Intellis Adaptivestim, Corevalve Evolut R |
| Esperion Therapeutics, INC. | $92.15 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $82.32 | 2019-2025 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $81.38 | 2024-2025 | Rexulti |
| Biohaven Pharmaceutical Holding Company Ltd. | $72.68 | 2022 | |
| Radius Health, INC. | $67.55 | 2024-2025 | Tymlos |
| Exact Sciences Corporation | $61.95 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Abbott Laboratories | $60.52 | 2021-2023 | Freestyle Libre 3 |
| Phathom Pharmaceuticals, INC. | $56.65 | 2025 | Voquezna |
| Inari Medical, INC. | $55.00 | 2024-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Glaxosmithkline, LLC. | $52.70 | 2019-2020 | |
| Hitachi Healthcare Americas Corp. | $47.32 | 2020 | |
| Dynavax Technologies Corporation | $44.64 | 2023-2024 | Heplisav-B |
| Arbor Pharmaceuticals, INC. | $43.69 | 2019-2020 | |
| Aimmune Therapeutics, INC. | $29.79 | 2025 | Zenpep |
| Merck Sharp & Dohme LLC | $28.11 | 2020 | |
| Janssen Pharmaceuticals, INC | $22.54 | 2019 | |
| Insmed, INC. | $20.08 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $19.16 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.00 | 2019 | |
| Inspire Medical Systems, INC. | $17.01 | 2025 | Inspire |
| Alnylam Pharmaceuticals INC. | $15.32 | 2023 | Onpattro |
| Nabriva Therapeutics, Plc | $14.63 | 2021 | |
| Dexcom, INC. | $14.42 | 2024 | Dexcom G6 Transmitter |
| Ibsa Pharma INC. | $13.36 | 2020 | |
| Hikma Pharmaceuticals USA | $13.29 | 2020 | |
| Eisai INC. | $10.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.